Xiidra (Page 3 of 3)
This Instructions for Use has been approved by the U.S. Food and Drug Administration. | Revised: June 2020 |
INSTRUCTIONS FOR USE XIIDRA® [ZYE-druh](lifitegrast ophthalmic solution) 5%for topical ophthalmic use | |
Read this Instructions for Use before you start using Xiidra and each time you get a refill. There may be new information. This leaflet does not take the place of talking to your doctor about your medical condition or your treatment. | |
Important Information You Need to Know Before Using Xiidra:
| |
Follow Steps 1 to 9 each time you use Xiidra. | |
Step 1. Take a foil pouch out of the Xiidra box. Open the pouch and remove the strip of single-use containers (see Figure A). | Figure A |
| Figure B |
Step 2. Put the remaining strip of single-use containers back in the pouch (see Figure C). | Figure C |
| Figure D |
Step 3. Hold the Xiidra container upright (see Figure E). | Figure E |
| Figure F |
Step 4. Open the Xiidra single-use container by twisting off the tab. Make sure that the tip of the single-use container does not touch anything, to avoid contamination (see Figure G). | Figure G |
Step 5. Tilt your head backwards. If you are not able to tilt your head, lie down. | |
Step 6. Gently pull your lower eyelid downwards and look up. Step 7. Place the tip of the Xiidra single-use container close to your eye, but be careful not to touch your eye with it. Step 8. Gently squeeze the single-use container and let one drop of Xiidra fall into the space between your lower eyelid and your eye. If a drop misses your eye, try again (see Figure H). | Figure H |
Step 9. Repeat Steps 5 to 8 for your other eye. There is enough Xiidra in one single-use container for both eyes.
| |
Distributed by: Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07936 |
T2020-89
PRINCIPAL DISPLAY PANEL
NDC 0078-0911-12
Rx Only
60 Single-Use
Containers:
12 pouches x 5 single-use
containers (0.2 mL each)
xiidra®
(lifitegrastophthalmic solution) 5%
NOVARTIS
XIIDRA lifitegrast solution/ drops | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
|
Labeler — Novartis Pharmaceuticals Corporation (002147023) |
Revised: 08/2023 Novartis Pharmaceuticals Corporation
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.